Glaucoma Specialists
Alan L. Robin, MD PA
Ophthalmology
Alan Robin is an expert in the field of Ophthalmology. He graduated from Tufts University School of Medicine. Tufts University School of Medicine is ranked 49/52 in Research/PrimaryCare. He over the years received 37 awards: "America's Top Doctors", "Top Doctors:Baltimore Area", "Top Doctors:Washington-Baltimore", "Best Doctors of America", "Americas Top Doctors", "Kapetansky Lecture, Midwest Glaucoma Symposium", "Consultant and Scientific Advisory Board, Aerie Pharmaceuticals", "Consultant and Scientific Advisory Board QLT", "Best Doctors in Maryland", "Hawaiian Eye Meeting Speaker of the Day", "Silver Fellow Award", "Secretariat Award", "Baltimore Magazine Top Doctor", "Consultant to Merck", "Consultant to Pfizer", "Scientific Advisory Board", "Top Winner", "Membership in Glaucoma Research Society", "Outstanding Humanitarian Service Award", "Nominee for the American Academy of Ophthalmology Humanitarian Award", "Life Time Member Global Directory of Whos Who", "Whos Who in the 21st Century", "Whos Who in America", "Baltimores Top Doctors", "Program Director", "Senior Honor Award", "Attending of the Year", "Janice Kushner Memorial Lecture for International Glaucoma Association", "Honorary member", "Associate Member", "Honor Award", "Research Excellence Award", "First Prize, Scientific Exhibit. The Use of Lasers in Glaucoma", "Heed Fellow", "ARVO Travel Award", "Resident Publication Award" and "Fellow (FAAO)". Alan Robin is also a published MD. He has 102 publication published. The most recent publication is: Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol. United States Latanoprost Study Group. He accepts all Medicare patients.
Publications
- Effectiveness of Glaucoma Counseling on Rates of Follow-up and Glaucoma Knowledge in a South Indian Population.
- Ophthalmologist-Patient Communication, Self-efficacy, and Glaucoma Medication Adherence.
- Potential Limitations of E-mail and Text Messaging in Improving Adherence in Glaucoma and Ocular Hypertension.
- TBK1 Gene Duplication and Normal-Tension Glaucoma.
- Provider Use of Collaborative Goal Setting with Glaucoma Patients.
- Determinants of Self-reported Barriers to Glaucoma Medicine Administration and Adherence: A Multisite Study.
- Duplication of TBK1 Stimulates Autophagy in iPSC-derived Retinal Cells from a Patient with Normal Tension Glaucoma.
- Identification of Proteins that Interact with TANK Binding Kinase 1 and Testing for Mutations Associated with Glaucoma.
- The relationship between Glaucoma medication adherence, eye drop technique, and visual field defect severity.
- A Video Study of Drop Instillation in Both Glaucoma and Retina Patients with Visual Impairment.
- Validation of a short version of the Glaucoma medication self-efficacy questionnaire.
- Copy number variations on chromosome 12q14 in patients with normal tension Glaucoma.
- The utility of relative afferent pupillary defect as a screening tool for Glaucoma: prospective examination of a large population-based study in a south Indian populat...
- Videotaped evaluation of eyedrop instillation in Glaucoma patients with visual impairment or moderate to severe visual field loss.
- Use of retinal procedures in medicare beneficiaries from 1997 to 2007.
- Glaucoma clinical trials.
- Trends in annual medicare expenditures for Glaucoma surgical procedures from 1997 to 2006.
- An objective evaluation of eyedrop instillation in patients with Glaucoma.
- Self-reported prevalence and factors associated with nonadherence with Glaucoma medications in veteran outpatients.
- Anterior juxtascleral delivery of anecortave acetate in Eyes with primary open-angle glaucoma: a pilot investigation.
- Predictors of and barriers associated with poor follow-up in patients with Glaucoma in South India.
- Utilization of various Glaucoma surgeries and procedures in Medicare beneficiaries from 1995 to 2004.
- Adherence in Glaucoma: objective measurements of once-daily and adjunctive medication use.
- Evaluation of Medicare costs of endophthalmitis among patients after Cataract surgery.
- An evaluation of how Glaucoma patients use topical medications: a pilot study.
- Patient-reported behavior and problems in using Glaucoma medications.
- Systemic medications and Glaucoma patients.
- Relationship between vision impairment and eye Disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey.
- Does adjunctive Glaucoma therapy affect adherence to the initial primary therapy?
- Preferences for eye drop characteristics among Glaucoma specialists: a willingness-to-pay analysis.
- Female reproductive factors and eye Disease in a rural South Indian population: the Aravind Comprehensive Eye Survey.
- Prevalence of vitreoretinal Disorders in a rural population of southern India: the Aravind Comprehensive Eye Study.
- The ocular hypertension treatment study: intraocular pressure lowering prevents the development of Glaucoma, but does that mean we should treat before the onset of dis...
- The utilization of eye care services by persons with Glaucoma in rural south India.
- Lens opacities in a rural population of southern India: the Aravind Comprehensive Eye Study.
- Blindness and vision impairment in a rural south Indian population: the Aravind Comprehensive Eye Survey.
- Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey.
- Pseudoexfoliation in a rural population of southern India: the Aravind Comprehensive Eye Survey.
- A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or Glaucoma.
- Update on prostaglandin analogs.
- Patient preferences for eye drop characteristics: a willingness-to-pay analysis.
- An accurate comparison of bimatoprost's efficacy and adverse effects.
- Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black Glaucoma subjects.
- Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric Glaucoma: a randomized clinical trial.
- Reduction of intraocular pressure with anecortave acetate in Eyes with ocular steroid injection-related glaucoma.
- First-year treatment patterns among new initiators of topical prostaglandin analogs.
- Patient-reported barriers to Glaucoma medication access, use, and adherence in southern India.
- Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for Glaucoma management: a United States perspective.
- Efficacy of brinzolamide and levobetaxolol in pediatric Glaucomas: a randomized clinical trial.
- Adjunctive Glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.
- Travoprost versus latanoprost combinations in Glaucoma: economic evaluation based on visual field deficit progression.
- Ocular trauma in a rural south Indian population: the Aravind Comprehensive Eye Survey.
- Safety and efficacy of mitomycin C trabeculectomy in southern India. A short-term pilot study.
- A long-term dose-response study of mitomycin in Glaucoma filtration surgery.
- Once-daily versus twice-daily levobunolol (0.5%) therapy. A crossover study.
- Attacking the backlog of India's curable blind. The Aravind Eye Hospital model.
- A limited comparison of apraclonidine's dose response in subjects with normal or increased intraocular pressure.
- Risk factors for age related Cataract in a rural population of southern India: the Aravind Comprehensive Eye Study.
- Helicobacter pylori IgG antibodies in aqueous humor and serum of subjects with primary open angle and pseudo-exfoliation Glaucoma in a South Indian population.
- The initial complication rate of phacoemulsification in India.
- Latanoprost treatment for Glaucoma: effects of treating for 1 year and of switching from timolol. United States Latanoprost Study Group.
- Posterior capsule tears during extracapsular Cataract surgery in India.
- Algorithm for interpreting the results of frequency doubling perimetry.
- Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for Glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group.
- Utilisation of eye care services in rural south India: the Aravind Comprehensive Eye Survey.
- Resuturing the scleral flap leads to resolution of Hypotony maculopathy.
- Effect of selected antihypertensives, antiDiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
- Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
- Compliance and adherence in Glaucoma management.
- Topical apraclonidine hydrochloride in Eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
- Clinically detectable nerve fiber atrophy precedes the onset of Glaucomatous field loss.
- Apraclonidine. A one-week dose-response study.
- Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy.
- Adjunctive Glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate.
- Long-term follow-up of neodymium: YAG laser angle surgery for open-angle Glaucoma.
- The role of apraclonidine hydrochloride in laser therapy for Glaucoma.
- Neodymium: YAG and argon laser iridotomy. Long-term follow-up in a prospective, randomized clinical trial.
- A combination of levobunolol and dipivefrin for the treatment of Glaucoma.
- Apraclonidine hydrochloride: an evaluation of plasma concentrations, and a comparison of its intraocular pressure lowering and cardiovascular effects to timolol maleate.
- Increased intraocular pressure in the immediate postoperative period after extracapsular Cataract extraction.
- Effectiveness of apraclonidine in preventing the rise in intraocular pressure after neodymium:YAG posterior capsulotomy.
- Effect of topical apraclonidine on the frequency of intraocular pressure elevations after combined extracapsular Cataract extraction and trabeculectomy.
- Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine.
- Effects of topical flurbiprofen on the intraocular pressure lowering effects of apraclonidine and timolol.
- Randomized clinical trials on medical treatment of Glaucoma: are they appropriate to guide clinical practice?
- Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine.
- Development of an instrument to measure Glaucoma medication self-efficacy and outcome expectations.
- Long-term results of extracapsular cataract extraction and posterior chamber intraocular Lens insertion in Nepal.
- The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers.
- The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine.
- Extracapsular Cataract extraction in Nepal. 2-year outcome.
- Argon laser trabeculoplasty medical therapy to prevent the intraocular pressure rise associated with argon laser trabeculoplasty.
- Evaluation of nerve fiber layer assessment.
- The role of alpha-agonists in Glaucoma therapy.
- Latanoprost in Glaucoma associated with Sturge-Weber syndrome: benefits and side-effects.
- Selectivity of site of action and systemic effects of topical alpha agonists.
- Flurbiprofen pretreatment in argon laser trabeculoplasty for primary open-angle Glaucoma.
- A long-term approach to eliminate cataract Blindness.
- The effect of argon laser trabeculoplasty on the medical control of primary open-angle Glaucoma.
- Q-switched neodymium-YAG laser angle surgery in open-angle Glaucoma.
- Communication Predicts Medication Self-Efficacy in Glaucoma Patients.
Schools
Tufts Univ Sch Of Med
Rochester Genl Hospital
Greater Baltimore Med Center
Wilmer Institute Johns Hopkins
Procedures Preformed
- Cataract Removal Surgery
- Cyclocryotherapy
- Cyclodiathermy
- Glaucoma Surgery
- View All
Conditions Treated
- Age-Related Macular Degeneration
- Anisocoria
- Aphakia and Other Disorders of Lens
- Bell's Palsy
- View All
Doctors Specialties
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:Baltimore Area
- Top Doctors:Washington-Baltimore
- Best Doctors of America
- America’s Top Doctors
- Kapetansky Lecture, Midwest Glaucoma Symposium
- Consultant and Scientific Advisory Board, Aerie Pharmaceuticals
- Consultant and Scientific Advisory Board QLT
- Best Doctors in Maryland
- Hawaiian Eye Meeting Speaker of the Day
- Silver Fellow Award
- Secretariat Award
- Baltimore Magazine Top Doctor
- Consultant to Merck
- Consultant to Pfizer
- Scientific Advisory Board
- Top Winner
- Membership in Glaucoma Research Society
- Outstanding Humanitarian Service Award
- Nominee for the American Academy of Ophthalmology Humanitarian Award
- Life Time Member Global Directory of Who’s Who
- Who’s Who in the 21st Century
- Who’s Who in America
- Baltimore’s Top Doctors
- Program Director
- Senior Honor Award
- Attending of the Year
- Janice Kushner Memorial Lecture for International Glaucoma Association
- Honorary member
- Associate Member
- Honor Award
- Research Excellence Award
- First Prize, Scientific Exhibit. The Use of Lasers in Glaucoma
- Heed Fellow
- ARVO Travel Award
- Resident Publication Award
- Fellow (FAAO)
Education
-
Tufts University School of Medicine
-
Yale University
Drug Facts
| NPI NUMBER |
|
1427010107 |
| NPPES Provider LastName |
|
ROBIN |
| NPPES Provider FirstName |
|
ALAN |
| NPPES Provider ZIPCode |
|
212092219 |
| NPPES Provider State |
|
MD |
| Specialty Description |
|
Ophthalmology |
| Total Claim Count |
|
1611.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1427010107 |
| Last Name Of The Provider |
ROBIN |
| First Name Of The Provider |
ALAN |
| View All |
|
Similar Doctors
|
Dr. Richard Semba, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. D C. Richa, MD
|
|
|
Dr. Allan D. Jensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Campochiaro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna H. Bordelon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Tso, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nguyen K. Ha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allen Silver, MD
|
|
|
Dr. Gail F. Schwartz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Celia S. Chen, MD
|
|
|
Dr. Ian F. Pitha, MD
This Doctor is OpenDoctor Recommended.
|
Doctor Directory | TOS | twitter | FB | Angel | blog